What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and enthusiasts. Medical Device News Magazine is a crucial source of information, providing valuable perspectives on state-of-the-art innovations, regulatory changes, FDA updates on medical devices, and industry trends affecting patient care and business approaches. Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking medical device news and articles authored by experts in this space. Medical Device News Magazine aims to stimulate discussions on advancements in medical devices and biotechnology, and their impact on the future of medicine.
The TheraLight FIT delivers powerful, clinically supported photobiomodulation therapy in a compact, easy-to-use design, bringing professional-grade light therapy to homes, wellness clinics, and sports performance environments without installation complexity or high costs.
The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to deliver superior efficiency for vitreoretinal and cataract surgery, while enabling exceptional outcomes for patients.
The Decipher Prostate test, already widely used for patients with localized disease, is now the only gene expression test available and covered by Medicare to inform treatment decisions for patients across the full continuum of prostate cancer risk.
While the impact of tariffs is currently the question at the forefront of healthcare executives’ minds, health systems can take proactive steps to protect themselves from supply chain disruptions of all sorts—including material shortages, labor strikes, or public health emergencies. Any of these scenarios could lead health systems to face higher costs and delayed access to supplies and parts, which can impact hospital efficiency and patient care.
This research, featured in Frontiers in Neuroscience, proposes a paradigm shift in understanding the function of Aβ, suggesting they may serve a protective role against metal toxicity in the brain rather than being primary culprits in AD progression.
“The goal of the Precision Study is to ensure that treatment with three radiation doses does not lead to greater side effects than those observed in the Pace-B study. I am confident that we can demonstrate effective cancer treatment with less side effects,” says Professor McLaren.
“This is an exciting new application of a known medication that, in addition to potentially protecting and/or expanding the beta cells that remain in early type 1 diabetes patients, might also be able to help other patients with diabetes to increase beta cell number and/or function,” said Fouad R. Kandeel, M.D., Ph.D., the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope and the trial’s co-principal investigator. “We are actively working to enroll qualified patients and look forward to seeing where this trial leads us.”
VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory (“EMBL”), and its technology transfer arm EMBLEM.
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe.
As this biomarker can be detected in blood, this test is a minimally invasive and broadly accessible diagnostic tool that may facilitate earlier detection of AD.
Investment will accelerate clinical trials and commercialization of Phantom X, with Ottobock joining Phantom Neuro’s Board of Directors
Funding to support commercialization of its groundbreaking bioresorbable vascular conduits notes Xeltis.
The BDD facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes.
Executives On The Move
Prior to joining Inari, Dr. Vivien Bonazzi served as chief biomedical data scientist and managing director at Deloitte Consulting LLP.
“Carrie Lachance has been at the center of InfuSystem’s succession plan for the past several years, and she is the ideal person to succeed Rich DiIorio having spent the last decade plus working her way up through ever greater positions of responsibility within the Company,” said Scott Shuda, Chairman of the board of InfuSystem.
“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in progressing our pipeline and delivering new treatment options for patients,” said Dr. Andrew Cavey, Chief Executive Officer of ITM.
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.
“These improvements underscore our dedication to supporting physicians in making informed decisions that improve patient outcomes. We believe the new features of HeartSee will set a new standard in cardiac care, helping to detect and treat coronary artery disease more effectively and efficiently than ever before,” said Derek Steptoe, Senior Manager of Nuclear Cardiology, Bracco.
SubtleHD sets a new benchmark in image quality and speed for European MRI providers.
Meghan Scanlon, senior vice president and president, Urology, Boston Scientific. “By closing this acquisition, we’re pleased to welcome the Axonics team into Boston Scientific. The addition of the Axonics product portfolio enables us to expand into sacral neuromodulation, a high-growth adjacency for our Urology business, while bringing a comprehensive portfolio of products to patients around the world who are seeking tailored treatment options based on their life stage and incontinence severity.”
Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific said, “We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases.”
“OCT technology enhances the level of care I am able to provide and has become a valuable tool in the operating room,” said Dr. Ana Wilson, a surgical oncologist with Covenant Health Fort Sanders Regional. “It allows me to make patient-specific surgical decisions in real-time and potentially reduce the likelihood of my patients returning for a second surgery.”
The Business of Healthcare
Surgeons face numerous risks during procedures, with eye protection being a paramount concern. Protecting surgeons’ vision is crucial, and laser safety glasses play a critical
Tips for Healthcare Professionals
So, how can one design bags and cases for medical professionals and students? This guide will share the details you need to know.
Healthcare Careers
Introduction As modern societies strive for better health outcomes, the role of health science professionals becomes increasingly vital. These experts are the backbone of efforts
Researchers from Florida Atlantic University’s Schmidt College of Medicine conducted a comprehensive study using data from the Youth Risk Behavior Survey between 2011 and 2021, which surveyed 88,183 adolescents in grades nine through 12. Researchers focused on the overall time trends in use of marijuana as well as variations by gender, race/ethnicity, and school grade. These data provide important insights into the changing landscape of marijuana use among American youth.
Published today in the Journal of Vascular and Interventional Radiology during Pain Awareness Month, the study of genicular artery embolization (GAE) followed 40 patients with moderate-to-severe symptomatic knee OA after their GAE treatment and measured pain scores throughout the 24-month study period. The patients were not candidates for total knee replacement.
They are calling on the Trump Administration to recalibrate their thinking of federal budget cuts to HHS and recognize that the health of individuals and communities as well as the economic repercussions would be dire. If HHS’s budget were cut this massively, the ripple effects would impact the longevity of the population.
The grant from Conexus MedStaff will aid the recovery and rehabilitation of community healthcare services in Naga City, which were severely affected by the devastation of Tropical Storm Kristine in October 2024.
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.
